BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12059059)

  • 1. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).
    Bretthauer M; Gondal G; Larsen K; Carlsen E; Eide TJ; Grotmol T; Skovlund E; Tveit KM; Vatn MH; Hoff G
    Scand J Gastroenterol; 2002 May; 37(5):568-73. PubMed ID: 12059059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years.
    Gondal G; Grotmol T; Hofstad B; Bretthauer M; Eide TJ; Hoff G
    Scand J Gastroenterol; 2003 Jun; 38(6):635-42. PubMed ID: 12825872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G
    JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I.
    Thiis-Evensen E; Hoff GS; Sauar J; Langmark F; Majak BM; Vatn MH
    Scand J Gastroenterol; 1999 Apr; 34(4):414-20. PubMed ID: 10365903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
    Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer in Italy: 2004 survey.
    Zorzi M; Grazzini G; Senore C; Vettorazzi M
    Epidemiol Prev; 2006; 30(1 Suppl 3):41-50. PubMed ID: 16937845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models.
    Wieszczy P; Kaminski MF; Løberg M; Bugajski M; Bretthauer M; Kalager M
    BMJ Open; 2021 Apr; 11(4):e042158. PubMed ID: 33853794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
    Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
    Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy screening for colorectal cancer.
    Bretthauer M; Skovlund E; Grotmol T; Thiis-Evensen E; Gondal G; Huppertz-Hauss G; Efskind P; Hofstad B; Thorp Holmsen S; Eide TJ; Hoff G
    Scand J Gastroenterol; 2003 Dec; 38(12):1268-74. PubMed ID: 14750648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of the effectiveness of population screening for colorectal cancer.
    Kerr J; Day P; Broadstock M; Weir R; Bidwell S
    N Z Med J; 2007 Jul; 120(1258):U2629. PubMed ID: 17653247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results.
    Buskermolen M; Gini A; Naber SK; Toes-Zoutendijk E; de Koning HJ; Lansdorp-Vogelaar I
    Med Decis Making; 2018 Nov; 38(8):917-929. PubMed ID: 30343626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
    Massat NJ; Moss SM; Halloran SP; Duffy SW
    J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening.
    Brown JP; Wooldrage K; Kralj-Hans I; Wright S; Cross AJ; Atkin WS
    J Med Screen; 2019 Mar; 26(1):11-18. PubMed ID: 30282520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of screening for colorectal cancer.
    Garborg K; Holme Ø; Løberg M; Kalager M; Adami HO; Bretthauer M
    Ann Oncol; 2013 Aug; 24(8):1963-72. PubMed ID: 23619033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.